Definitive Healthcare Reports Third-Quarter 2026 Revenue of $54.7 Million
Revenue fell 9% year over year to $54.7 million. The company reported a net loss of $5.4 million, compared with $17.8 million a year earlier, and adjusted EBITDA of $15.7 million versus $18.9 million. Operating cash flow was $11.4 million and unlevered free cash flow was $13.0 million. Definitive Healthcare said it will not provide guidance or host a conference call on the results.
Definitive Healthcare Corp. reported third-quarter 2026 revenue of $54.7 million, representing a 9% decrease from the $60.0 million reported in the same period of 2025. The company recorded a net loss of $5.4 million, or 10% of revenue, compared to a net loss of $17.8 million, or 30% of revenue, in the third quarter of 2025. Adjusted EBITDA for the quarter was $15.7 million, or 29% of revenue, down from $18.9 million, or 32% of revenue, in the prior-year period.
The company also reported $11.4 million in cash flow from operations and $13.0 million in unlevered free cash flow. Definitive Healthcare stated that it will not provide financial guidance or host a conference call to discuss these quarterly results.